Arkolith/Insider Trading/TYRA/Form 4

Bensen Daniel

Chief Discovery OfficerTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Feb 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$263K
Net Open-Market Flow
-$263K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2026Sell(S)2K$31.50$67K153K
Feb 12, 2026Sell(S)6K$33.37$196K147K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-051534) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML